Results 91 to 100 of about 840,733 (199)
Macromolecular Rapid Communications, EarlyView.We report here a new methodology to prepare functional poly(acetylene)s under aqueous conditions. This methodology is underpinned by poly(O‐propargyl‐N‐amino carbamate) (P1), a reactive poly(acetylene) carrying acyl hydrazines. Thus, P1 reacts with aldehydes to give functional poly(acetylene)s, including cationic, hydrophobic, and sugar‐loaded poly ...
Tom Leigh +8 more
wiley +1 more source
, 2015 The CIAT Management Team proposed the creation of an independent, not-for-profit entity that would contribute more effectively and efficiently to CIAT's mission in Latin America and the Caribbean (LAC)
Agronatura
core
Differentiating Nonsuicidal Self‐Injury (NSSI) From Suicide Attempts in Adolescents: A Pilot Study
Medicine Bulletin, EarlyView.ABSTRACT Background Differentiating between nonsuicidal self‐injury (NSSI) and suicide attempts (SA) in adolescents is crucial due to distinct underlying motivations, treatment needs, and potential outcomes associated with each behavior.
María Posada‐Ayala +9 more
wiley +1 more source
Assessment of the conservation status of natural and semi-natural patches associated with urban areas through habitat suitability indices [PDF]
, 2015 Urban environments rely on the surrounding natural ecosystems remnants as providers of ecosystem functions, therefore these areas not only support a unique biodiversity but also have a social value for maintaining public health and wellbeing.
Junquera, J. E. +3 more
core
High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.Abstract Background DOPA decarboxylase (DDC) in cerebrospinal fluid (CSF) is an emerging Parkinson's disease (PD) biomarker, but its association with nonmotor symptoms is unclear. Objectives We aimed to determine if baseline DDC was associated with future cognitive decline in PD.
Andrea Sturchio +7 more
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background α‐synuclein seeding amplification assay (α‐synuclein SAA) development as a diagnostic biomarker for Parkinson's disease (PD) has shown promising results over the past decade. However, the utility of these assays in the prediction of disease progression is unclear.
Daniel Belete +5 more
wiley +1 more source
Defining Quality of Life: The Perspective of People Living with Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.Abstract Background Little is known about how people with Parkinson's conceptualize “quality of life.” Objective To describe the meaning of “quality of life” from the perspective of people with Parkinson's. Methods Participants (N = 42) were asked “What does the term ‘quality of life’ mean to you?” Definitions were analyzed using inductive qualitative ...
Samantha Dorrance +13 more
wiley +1 more source
Movement Disorders, EarlyView.Abstract Background Peripheral disease mechanisms such as immune dysregulation may contribute to Parkinson's disease (PD). To investigate interactions between common PD mutations and immune responses to environmental pathogens, we studied responses to Pseudomonas aeruginosa (P.
Julian R. Mark +8 more
wiley +1 more source
Movement Disorders, EarlyView.Abstract Background GBA1 variants cause Gaucher's disease (GD) in biallelic forms and increase Parkinson's disease (PD) risk in heterozygous carriers. Carriers of mild or severe variants (causing GD type 1 or types 2–3) can enroll in clinical trials, whereas those with GBA1 variants classified as unknown are typically excluded.
Sitki Cem Parlar +2 more
wiley +1 more source
It Is Personal: What People with Parkinson's Disease Say Matters Most for Quality of Life
Movement Disorders, EarlyView.Abstract Background Little is known about what matters most for quality of life in people with Parkinson's disease and how much it varies between individuals. Objective The goal was to define the relative impact of quality of life determinants in people with Parkinson's disease, including variation across individuals and by disease severity, gender ...
Samantha Dorrance +13 more
wiley +1 more source